(MedPage Today) — The emergence of immunotherapy for esophageal cancer provided a glimmer of hope to patients and clinicians affected by the historically poor-prognosis disease. The glimmer has not only persisted but perhaps grown brighter as…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
